Lab 2 - Question #1: (10 points) Preventing mother-to-child...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Question #1: (10 points) Preventing mother-to-child HIV transmission is obviously of paramount importance when treating pregnant women that are HIV-positive. According to the Public Health Service Task Force, when is it okay for a patient to take Nevirapine if she is pregnant, has HIV, and has never taken any antiretroviral therapy drugs? That is, for what CD4+ counts is it considered okay? What is the risk (side-effect) involved with taking Nevirapine? What is Nevirapine's mode of action? Maximum number of words: 400 1) If the patient has HIV, and has never taken any antiretroviral should ask her doctor before taking Nevirapine because this drug can affect fetus in potential short and long term, but this drug not significantly alter when the patient is pregnant, so she does not need to change the dose requirement. 2) The CD4+ counts <250 cells/mm3 would be okay. 3) The side-effects of taking Neirapine are having headache and diarrhea. 4) Neirapine is a medicine which can prevent the patients from getting the related
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 02/25/2009 for the course CHEM 17275 taught by Professor Brutcheyjr during the Spring '08 term at USC.

Page1 / 2

Lab 2 - Question #1: (10 points) Preventing mother-to-child...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online